Triple Negative Breast Cancer Unmet Medical Needs

Providing Therapies For Unmet Medical Needs In Oncology ...
Providing Therapies for Unmet Medical Needs in Oncology & Endocrinology . Therapeutic focus on key areas of unmet medical needs – oncology and endocrinology triple-negative breast and prostate cancer ... Access Content

FOR IMMEDIATE RELEASE AVEO And Astellas Discontinue Phase 2 ...
AVEO and Astellas Discontinue Phase 2 Trial of Tivozanib in Breast Cancer lives by addressing unmet medical needs. patients with triple negative breast cancer; and AVEO and Astellas’ plans to evaluate the data ... Doc Viewer

Providing Therapies For Unmet Medical Needs In Oncology ...
Providing Therapies for Unmet Medical Needs in Oncology & Endocrinology . Aeterna Zentaris . Forward Looking Statement . Macimorelin Cancer Induced Cachexia (1) MACRILENTM Evaluate(macimorelin) AGHD Perifosine Multiple Cancers (3) ... Access Content

Breast Cancer - YouTube
The video material in this ESMO Playlist about Breast Cancer covers various educational and scientific aspects, Triple Negative Breast Cancer: complex topic, Directing breast cancer biology and science towards unmet medical needs by European Society for Medical Oncology. 3:43. ... View Video

Women And Health Focus On Breast Cancer
Unmet medical need * Including Palliative Care. 3 Breast Cancer breast cancer share their needs and preferences for information, support and practical service. http Early Breast Cancer HR+ HER2+ Triple Negative Endocrine therapy Chemotherapy ... View Doc

Phoenix Molecular Designs - Static1.squarespace.com
Canadian Breast Cancer Foundation 85 publications Cited >4500 times 400,000 women are diagnosed with Triple Negative Breast Cancer (TNBC) every year. This is which, until now has no targeted treatment making it one of the greatest unmet medical needs in the pharmaceutical industry ... Fetch Document

Sanofi-aventis Reports Top-line Results From Phase III Study ...
Committed to improving outcomes for patients with triple negative breast cancer where there is high unmet medical need." effective cancer therapeutics to address unmet medical needs for patients with cancer. Starting with a deep ... Document Viewer

January 2016 - Shareholder
Human Triple-Negative Breast Cancer (MDA-MB-231) HIGH UNMET MEDICAL NEED • Triple Negative Breast Cancer (TNBC) –no approved therapy; poor • Differentiated products targeting unmet medical needs Novel products targeting broad spectrum ... Retrieve Document

COMPANY HIGHLIGHTS - CASI Pharmaceuticals
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs. ... Access Full Source

PHASE III STUDY (STUDY 301) RESULTS OF ANTICANCER AGENT ...
Although advances are being made in the treatment of breast cancer each year in line with the development of new anticancer agents, the unmet medical needs of locally advanced or metastatic breast ... Fetch Here

Final Results From Phase II Study Confirm BSI-201 (Iniparib ...
In Metastatic Triple Negative Breast Cancer - Data presented at 35th European Society for Medical Oncology (iniparib) group showed a Sanofi-aventis Oncology is targeting cancer on all fronts in an effort to address unmet medical needs for a ... Document Viewer

Pfizer Pipeline
Pfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of April 28, PF-03084014 Gamma-Secretase Inhibitor Triple Negative Breast Cancer Phase 2 and it demonstrates the potential to address unmet medical needs for ... Fetch Doc

Molecularly Targeted Therapies For Metastatic triple-negative ...
Molecularly targeted therapies for metastatic triple-negative breast cancer Department of Medical Oncology, Mercy Cancer Center, Ardmore, OK, USA e-mail: Gianni L (2011) Triple-negative breast cancer: an unmet medical need. Oncologist 16(Suppl 1):1–11. doi:10.1634/ theoncologist.2011 ... Document Viewer

Hypoxia-inducible Factor 1-dependent Expression Of Platelet ...
In women with triple-negative breast cancer. 1. Schindl M, et al.; Austrian Breast andColorectal Cancer Study Group (2002) Triple negative breast cancer: Unmet medical needs. Breast Cancer Res Treat 125:627–636. 6. Zhang H, et al. (2012) HIF-1-dependent expression of angiopoietin-like 4 ... Document Viewer

IMMUNOMEDICS AWARDED FAST TRACK DESIGNATION FOR IMMU-132 FOR TNBC
IMMUNOMEDICS AWARDED FAST TRACK DESIGNATION BY FDA FOR TRIPLE-NEGATIVE BREAST CANCER THERAPY Morris Plains, NJ, January 5, 2015 --- Immunomedics, Inc., (Nasdaq: IMMU which also constitutes an unmet medical need and where ... Get Document

New Data In Breast And Ovarian Cancer Presented At ASCO ...
New Data in Breast and Ovarian Cancer Presented at ASCO Support Continued Development of Iniparib in metastatic triple-negative breast cancer (mTNBC), platinum-sensitive and platinum-resistant effective cancer therapeutics to address unmet medical needs for patients with cancer. ... Access Full Source

BRCA Genetic Testing For Patients With And Without Breast Cancer
In many areas of the country, breast surgeons can fill the unmet need for appropriate counseling of these high-risk patients. Medical and ethical implications of the decision to share information with at-risk relatives if women with triple negative breast cancer. BMC Cancer. 2009; ... Fetch This Document

Post-Hearing Submission Of Genentech, Inc. In Support Of ...
There Are Significant Unmet Medical Needs in First-Line Metastatic Breast Triple Negative Breast Cancer Foundation, Docket No. FDA-2010-N-0621 hormone receptor-positive tumors are particularly acute unmet medical needs within MBC. Avastin is an important treatment for patients with ... Read Here

Re: Docket No. FDA-2012-D-0432: Draft Guidance For Industry ...
Breast Cancer: Use as an Endpoint to Support Accelerated Approval.” BIO commends FDA on releasing this Draft Guidance, for Unmet Medical Needs . We hope that FDA considers expanding the use of pCR as a surrogate endpoint to a ... Fetch Full Source

Personalized Medicine - Wikipedia, The Free Encyclopedia
Personalized medicine is a medical model that genotyped for certain mutations in the BRCA1 and BRCA2 gene if they are predisposed because of a family history of breast cancer or or “Oncogenomics,” is the application of genomics and personalized medicine to cancer research ... Read Article

The Value Of Medicine In Metastatic Breast Cancer (mBC)
1 KEY TAKEAWAYS Breast cancer is the most common cancer in women worldwide.5 The global impact of breast cancer due to disability and premature deaths, not ... Retrieve Full Source

RESEARCH Open Access Combining Phenotypic And Proteomic ...
RESEARCH Open Access Combining phenotypic and proteomic approaches to identify membrane targets in a triple negative breast cancer cell type ... Retrieve Content